Laustsen, A. H., Gutiérrez, J. M., Knudsen, C., Johansen, K. H., Bermúdez Méndez, E., Cerni, F. A., . . . Pucca, M. B. (2018). Pros and cons of different therapeutic antibody formats for recombinant antivenom development.
Citación estilo ChicagoLaustsen, Andreas Hougaard, et al. Pros and Cons of Different Therapeutic Antibody Formats for Recombinant Antivenom Development. 2018.
Cita MLALaustsen, Andreas Hougaard, et al. Pros and Cons of Different Therapeutic Antibody Formats for Recombinant Antivenom Development. 2018.
Precaución: Estas citas no son 100% exactas.